Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis.

BACKGROUND The number and volume of abnormalities on baseline brain magnetic resonance images in patients with initial findings suggestive of multiple sclerosis are known to predict outcome in terms of disability. However, no long-term data exist on specific locations or types of lesions. OBJECTIVE To assess the long-term predictive value of baseline magnetic resonance imaging parameters, including location of lesions and gadolinium-enhancing and hypointense lesions in patients with initial findings suggestive of multiple sclerosis for the occurrence of clinically relevant disability as defined by an Expanded Disability Status Scale score of 3. PATIENTS After a median follow-up period of 8.7 years, the medical records of 42 patients were reviewed and assessed for time until patients received an Expanded Disability Status Scale score of 3. Magnetic resonance imaging parameters were dichotomized according to maximum accuracy and then used to calculate hazard ratios using the Cox model for proportional hazard ratios. RESULTS Conversion to clinically definite multiple sclerosis was observed in 26 patients (62%), of whom 14 (54%) progressed to an Expanded Disability Status Scale score of 3. Two or more infratentorial lesions best predicted long-term disability (hazard ratio, 6.3). Gadolinium-enhancing and hypointense T1-weighted lesions did not show prognostic value. CONCLUSION Infratentorial lesions are related to long-term prognosis for patients with initial findings suggestive of multiple sclerosis and thus may help to identify patients at high risk for earlier occurrence of clinically relevant disability.

[1]  Michael Wall,et al.  MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group , 2002, Neurology.

[2]  David H. Miller,et al.  A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. , 2002, The New England journal of medicine.

[3]  S. Hickman,et al.  Infratentorial hypointense lesion volume on T1-weighted magnetic resonance imaging correlates with disability in patients with chronic cerebellar ataxia due to multiple sclerosis , 2001, Journal of the Neurological Sciences.

[4]  Marco Rovaris,et al.  Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study , 2001, The Lancet.

[5]  J H Simon,et al.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. , 2000, The New England journal of medicine.

[6]  F. Barkhof,et al.  Magnetization Transfer Ratio of the Spinal Cord in Multiple Sclerosis: Relationship to Atrophy and Neurologic Disability , 2000, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[7]  M. Filippi,et al.  Assessment of posterior fossa damage in MS using MRI , 2000, Journal of the Neurological Sciences.

[8]  F. Barkhof,et al.  Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.

[9]  I. Moseley,et al.  Multisequence MRI in clinically isolated syndromes and the early development of MS , 1999, Neurology.

[10]  Ludwig Kappos,et al.  Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis , 1999, The Lancet.

[11]  F Barkhof,et al.  Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis: relation to inflammatory activity. , 1999, Archives of neurology.

[12]  A J Thompson,et al.  Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. , 1999, Neurology.

[13]  Jonathan D. Trobe,et al.  The 5-year risk of MS after optic neuritis , 1998, Neurology.

[14]  G. Barker,et al.  Spinal cord atrophy and disability in MS , 1998, Neurology.

[15]  F. Barkhof,et al.  Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. , 1998, Brain : a journal of neurology.

[16]  A. Thompson,et al.  The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. , 1998, Brain : a journal of neurology.

[17]  G. Comi,et al.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.

[18]  F. Barkhof,et al.  Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis , 1996, Neurology.

[19]  A. Thompson,et al.  Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. , 1996, Brain : a journal of neurology.

[20]  C. Polman,et al.  The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. , 1995, AJNR. American journal of neuroradiology.

[21]  R. R. Smith,et al.  MRI in acute disseminated encephalomyelitis , 1994, Neuroradiology.

[22]  W. I. McDonald,et al.  Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis , 1994, Neurology.

[23]  R. Beck,et al.  The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. , 1993, The New England journal of medicine.

[24]  D. Miller,et al.  The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. , 1993, Brain : a journal of neurology.

[25]  B. Ford,et al.  Long‐term follow‐up of acute partial transverse myelopathy , 1992, Neurology.

[26]  D. Li,et al.  Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: A prospective 2‐year follow‐up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT , 1991, Neurology.

[27]  F. Munschauer,et al.  Clinical and magnetic resonance imaging in optic neuritis , 1991, Neurology.

[28]  B. Stern,et al.  Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. , 1990, AJNR. American journal of neuroradiology.

[29]  S. Holtås,et al.  A long‐term prospective study of optic neuritis: Evaluation of risk factors , 1990, Annals of neurology.

[30]  J. Rizzo,et al.  Risk of developing multiple sclerosis after uncomplicated optic neuritis , 1988, Neurology.

[31]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[32]  D. Miller,et al.  MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis , 2004, Neuroradiology.